Robot-Assisted Partial Nephrectomy with a New Robotic Surgical System: Feasibility and Perioperative Outcomes.

Journal: Journal of endourology
Published Date:

Abstract

The aim of this study was to evaluate the feasibility and safety of a novel robotic system (KD-SR-01) for partial nephrectomy. Seventeen patients with small renal masses (SRMs) (≤4 cm) underwent KD-SR-01 robotic partial nephrectomy (KD-RPN) from December 2020 to March 2021 in our institution. The operative outcomes and perioperative data, including clinical and histological data, were prospectively collected and analyzed. In total, 10 men and 7 women, with a median age of 51 years, underwent KD-RPN. Four transperitoneal procedures and 13 retroperitoneal procedures were performed without conversion to open or conventional laparoscopic surgery. The docking time and robotic operative time were 3.3 and 68.6 minutes, respectively. The warm ischemia time was 16.9 minutes. No major intraoperative or postoperative complications (Clavien grade ≥III) occurred. The duration of postoperative hospital stay was 5 days. Pathologic examination revealed nine clear cell carcinoma, two papillary cell carcinoma, one oncocytoma, and five angiomyolipoma cases. All surgical margins were negative. The estimated glomerular filtration rate (eGFR) on the first postoperative day was significantly decreased compared with the preoperative eGFR (91.7 ± 12.9 mL/min 97.9 ± 10.7 mL/min,  = 0.036). However, no significant difference was observed between the preoperative eGFR and the value on the fourth postoperative day (95.7 ± 13.4 mL/min 97.9 ± 10.7 mL/min,  = 0.427). KD-RPN was safe and feasible for treatment of SRM. The early oncologic and functional outcomes were promising. Long-term follow-up and well-designed prospective comparative studies with the da Vinci platform are needed to corroborate these findings.

Authors

  • Weifeng Xu
    Department of Urology, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
  • Jie Dong
    Department of Urology, Eastern Theater Command General Hospital, Nanjing,Jiangsu 210002, Chinia.
  • Yi Xie
    Department of Plastic Surgery Peninsula Health Melbourne Victoria Australia.
  • Guanghua Liu
    Department of pediatrics, Fujian Provincial Maternity and Children's Hospital, Fuzhou, Fujian, China.
  • Jingmin Zhou
    Department of Urology, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
  • Huizhen Wang
    Department of Rehabilitation Medicine, The 8th Medical Center of Chinese PLA General Hospital, Beijing,100091, China. whz01062020@163.com.
  • Shengjie Zhang
    CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Hui Wang
    Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Zhigang Ji
    Department of Urology, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
  • Liang Cui
    Department of Urology, Civil Aviation General Hospital, Civil Aviation Medical College of Peking University, Beijing, China.